Medications

FDA approves biosimilar ogivri for breast, stomach cancers

(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.

Psychology & Psychiatry

Depressed with a chronic disease? Consider alternative therapies

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact ...

Cardiology

MACE risk similar for white men, women, minorities after PCI

(HealthDay)—Women and minorities undergoing percutaneous coronary intervention (PCI) with everolimus-eluting stents have a risk of major adverse cardiac events (MACE) that is similar to that of white men, according to a ...

Overweight & Obesity

Health of more than half of US adults affected by obesity

Considering weight across the life course, the prevalence of obesity among adults in the US rises considerably, suggesting that the effects on population health may be even more pervasive than previously understood, according ...

page 13 from 36